107 results on '"Daneault B"'
Search Results
2. VALIDATION OF MYCOPLASMA STABILITY IN SNAP-FROZEN CULTURED CELLS IN MEDIA TO ENABLE BATCHING OF PCR TESTING
3. CHANGE MANAGEMENT IN AN EXPANDING, MAJOR ACADEMIC CELLULAR THERAPY FACILITY
4. Process Development and Manufacturing: INCREASING PATIENT ACCESS AND SCALABILITY OF IMMUNOTHERAPY USING A UNIVERSAL DONOR APPROACH
5. Process Development and Manufacturing: ONE YEAR FROM VECTOR TO BEDSIDE: RAMPING UP A SUCCESSFUL IN-HOUSE CAR T-CELL MANUFACTURING PROGRAM USING A NOVEL TRI-SPECIFIC CAR T-CELL THERAPY FOR LYMPHOID MALIGNANCIES
6. Process Development and Manufacturing: CRYOPRESERVATION METHOD OPTIMIZATION FOR PLACE-OF-CARE MANUFACTURING OF A FIRST IN HUMAN TRI-SPECIFIC CAR T-CELL THERAPY PRODUCT FOR LYMPHOID MALIGNANCIES
7. REAL-WORLD DATA OVER TIME FOR TRANSCATHETER AND SURGICAL AORTIC VALVE INTERVENTIONS IN QUÉBEC
8. ANTITHROMBOTIC THERAPIES IN CANADIAN ATRIAL FIBRILLATION PATIENTS WITH CONCOMITANT CORONARY ARTERY DISEASE: INSIGHTS FROM THE CONNECT AF+PCI-I AND -II PROGRAMS
9. L’apéline, une nouvelle molécule prometteuse dans le traitement de la défaillance cardiaque aiguë ?
10. The Effect of Fold Dilution on Cord Blood Thaw Methods: SP432
11. EVOLUTION OF TRANSVALVULAR GRADIENTS AFTER TAVR ACCORDING TO USE OF ANTICOAGULATION THERAPY
12. Cell Processing Tracer Audits to Monitor Documentation of Critical Processing Elements: AP118
13. Cell Product Clumping During Processing: SP328
14. Red Blood Cell Contamination in Major ABO Incompatible HPC, Apheresis Fresh Infusion: S51-030D
15. Rationale for Assessing Viability of Every Cell Product Within 7 Days of Cryopreservation: SP67
16. Establishing Environmental Control and Monitoring Program in an Unclassified, Non-Clean Room Cell Processing Facility: SP44
17. CONTEMPORARY USE OF ORAL ANTITHROMBOTIC THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE CONNECT AF+PCI STUDY
18. SEX BIAS FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR REFERRAL FOR PRIMARY PREVENTION IN HEART FAILURE WITH REDUCED EJECTION FRACTION
19. CONTEMPORARY INCIDENCE OF MURAL THROMBUS FOLLOWING ACUTE ANTERIOR STEMI COMPLICATED BY NEW ANTERO/APICAL WALL MOTION ABNORMALITIES: INSIGHTS FROM THE MULTICENTER MAGIC REGISTRY
20. PREVENTION OF LEFT VENTRICULAR THROMBUS FORMATION AND SYSTEMIC EMBOLISM AFTER ANTERIOR MYOCARDIAL INFARCTION: A SYSTEMATIC LITERATURE REVIEW
21. TRANSCATHETER AORTIC VALVE IMPLANTATION IN QUÉBEC: 4 YEARS OF COMPREHENSIVE EVALUATION AND RELATION TO QUALITY INDICATORS
22. MANAGEMENT OF STEMI WITH ANTERIOR WALL MOTION ABNORMALITIES USING TRIPLE VERSUS DOUBLE ANTI-THROMBOTIC THERAPY: THE MAGIC MULTICENTER RETROSPECTIVE REGISTRY
23. RISK PROFILE AND IMPACT OF PHARMACOLOGICAL THROMBOPROPHYLAXIS ON BLEEDING EVENT AND OUTCOME: INSIGHTS FROM A CONTEMPORARY STEMI PROSPECTIVE REGISTRY
24. EVALUATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION IN QUÉBEC USING NEWLY-ESTABLISHED CANADIAN CARDIOVASCULAR SOCIETY QUALITY INDICATORS
25. USE AND OUTCOMES OF TRANSCATHETER AORTIC VALVE IMPLANTATION: RESULTS OF A QUÉBEC-WIDE FIELD EVALUATION
26. WHAT ARE THE BEST INDICATORS OF THE PERFORMANCE OF TRANSCATHETER AORTIC VALVE IMPLANTATION? MEASURES OF QUALITY IN QUÉBEC COMPARED WITH INTERNATIONAL REGISTRIES
27. SAFETY OF TICAGRELOR AFTER A PRASUGREL LOADING DOSE IN STEMI PATIENTS
28. USE AND OUTCOMES OF TRANSCATHETER AORTIC VALVE IMPLANTATION: Results OF A QUÉBEC-WIDE FIELD EVALUATION AND COMPARISON WITH THE TVT REGISTRY
29. Value of Stress Echocardiography for Further Evaluation of Equivocal Treadmill Test at High Workload (Over 11 Mets)
30. Comparison of Three-Year Outcomes After Primary Percutaneous Coronary Intervention in Patients With Left Ventricular Ejection Fraction <40% Versus >=40% (from the HORIZONS-AMI Trial)
31. Stroke associated with surgical and transcatheter treatment of aortic stenosis: a comprehensive review.
32. 825 - Process Development and Manufacturing: ONE YEAR FROM VECTOR TO BEDSIDE: RAMPING UP A SUCCESSFUL IN-HOUSE CAR T-CELL MANUFACTURING PROGRAM USING A NOVEL TRI-SPECIFIC CAR T-CELL THERAPY FOR LYMPHOID MALIGNANCIES.
33. 903 - Process Development and Manufacturing: CRYOPRESERVATION METHOD OPTIMIZATION FOR PLACE-OF-CARE MANUFACTURING OF A FIRST IN HUMAN TRI-SPECIFIC CAR T-CELL THERAPY PRODUCT FOR LYMPHOID MALIGNANCIES.
34. Restrictive Versus Liberal Transfusion in Patients with Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the Myocardial Ischemia and Transfusion (MINT) Trial.
35. Restrictive or Liberal Transfusion Strategy in Myocardial Infarction and Anemia.
36. Outcome of STEMI Patients With Reperfusion Delay of 120 Minutes or More Treated With the Pharmacoinvasive Approach vs PPCI: A Retrospective Study.
37. Antithrombotic Management and Outcomes of Anterior ST-Elevation Myocardial Infarction With New-Onset Wall Motion Abnormalities in Men and Women.
38. Deep Septal Perforation During Left Bundle Branch Area Pacing Resulting in Left Ventricular Capture and Delayed Systemic Embolism.
39. Antithrombotic therapies in Canadian atrial fibrillation patients with concomitant coronary artery disease: Insights from the CONNECT AF + PCI-II program.
40. Rationale and Design of the Randomized Bayesian Multicenter COME-TAVI Trial in Patients With a New Onset Left Bundle Branch Block.
41. Contemporary incidence and predictors of left ventricular thrombus in patients with anterior acute myocardial infarction.
42. Oral Anticoagulation for the Prevention of Thromboembolic Events in Patients With Anterior ST-Segment Elevation Myocardial Infarction.
43. Double-blind, placebo-controlled evaluation of biorest liposomal alendronate in diabetic patients undergoing PCI: The BLADE-PCI trial.
44. Use of antithrombotic therapy for secondary prevention in patients with stable atherosclerotic cardiovascular disease: Insights from the COordinated National Network to Engage Cardiologists in the antithrombotic Treatment of patients with CardioVascular Disease (CONNECT-CVD) study.
45. Antithrombotic Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation: Findings From the CONNECT AF+PCI Study.
46. Drug-coated balloon after subintimal plaque modification in failed coronary chronic total occlusion percutaneous coronary intervention: A novel concept.
47. Inequity in Access to Transcatheter Aortic Valve Replacement: A Pan-Canadian Evaluation of Wait-Times.
48. Comparison of Systematic Ticagrelor-Based Dual Antiplatelet Therapy to Selective Triple Antithrombotic Therapy for Left Ventricle Dysfunction Following Anterior STEMI.
49. LVT Prophylaxis After Anterior ST-Elevation Myocardial Infarction: A Response to Marquis-Gravel et al.
50. Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.